Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Botox Injection Reduces Post-Surgical Scarring

By HospiMedica staff writers
Posted on 11 Sep 2006
A new study has found that injection of botulinum toxin (botox) within 24 hours of wound closure in the forehead results in less long-term scarring. More...


A study by researchers from the University of Buffalo (NY, USA) examined whether botox-induced immobilization of facial lacerations enhances wound healing and results in less-noticeable scars. The study included 31 patients who suffered wounds to the forehead or had surgery to remove skin cancers from the forehead. The patients received either an injection of botox or saline within 24 hours after wound closure. Photographs were taken at the time the patients received the injections and again six months later, and were reviewed by two facial plastic surgeons who were not involved in the study.

The reviewers used a 10-cm visual analog scale, rating the patients' wound healing on a scale of zero to 10, with 10 representing the best result. The two surgeons' scores were averaged to reach a final score for each patient. The median scores for wounds injected with botox were 8.9, compared to 7.1 for wounds injected with saline. The study was published in the August 2006 issue of Mayo Clinic Proceedings.

"This is the first medication found to minimize scarring,” said senior author Dr. David Sherris, professor and chair of the department of otolaryngology. "The result is of substantial interest in the field of scar treatment. When a wound occurs, especially on the face, people are always worried about the scar. We can now try to improve scars with these injections.”

Botox is the toxic compound produced by the bacterium Clostridium botulinum. It is a protease that breaks down one of the fusion proteins--docking proteins that anchor the vesicle to the membrane--allowing neurons to release acetylcholine at a neuromuscular junction. By inhibiting acetylcholine release, the toxin interferes with nerve impulses and causes paralysis of muscles. A popular use for botox is injection into facial muscles to temporarily relax those muscles to lessen or eliminate wrinkles.



Related Links:
University of Buffalo

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.